Comparação entre pico de torque e flexibilidade dos membros inferiores de indivíduos com e sem diabetes mellitus tipo 2

Suzane Stella Bavaresco; Luma Zanatta de Oliveira; José Carlos dos Santos Albarello; Alexandre Pereira Tognon; Cleiton Chiamonti Bona; Luiz Antonio Bettinelli; Camila Pereira Leguisamo

doi:10.1590/1809-2950/17024826022019

Authors

Suzane Stella Bavaresco Universidade de Passo Fundo https://orcid.org/0000-0003-1615-164X
Luma Zanatta de Oliveira Universidade de Passo Fundo https://orcid.org/0000-0003-4352-3066
José Carlos dos Santos Albarello Universidade de Passo Fundo https://orcid.org/0000-0001-5963-4866
Alexandre Pereira Tognon Universidade de Passo Fundo https://orcid.org/0000-0002-1035-2793
Cleiton Chiamonti Bona Universidade de Passo Fundo https://orcid.org/0000-0003-3269-3879
Luiz Antonio Bettinelli Universidade de Caxias do Sul https://orcid.org/0000-0002-7029-6834
Camila Pereira Leguisamo Universidade Luterana do Brasil https://orcid.org/0000-0001-9305-8241

DOI:

https://doi.org/10.1590/1809-2950/17024826022019

Keywords:

Muscle Strength, Type 2 Diabetes Mellitus, Muscle Strength Dynamometer, Torque, Lower Extremity

Abstract

To compare the muscle strength and flexibility of the lower limbs of individuals with and without T2DM. The method was a study of the types exposed and unexposed to T2DM. Individuals diagnosed with T2DM, individuals referred to electromyography, and those unexposed to T2DM were included. The exclusion criteria were: individuals over 70 years old; those who for some reason failed to complete one or both tests. The study population consisted of 64 individuals; 34 (53.1%) exposed to DM and 30 unexposed, 50 (78.1%) were female, the mean age was 60.7±7.1 and the dominant lower limb was right in 57 (89.1%) individuals. Comparing individuals with and without a diagnosis of DM, one observed a reduction in the flexion torque on the left at a 120 ° angular velocity in diabetics individuals compared with nondiabetic patients, 25.94±2.26 vs 33.79±2, 4nm, p=0.027, respectively. The reduction in dorsiflexion torque on the right, at a 60 ° angular velocity was observed in diabetics compared with nondiabetic patients, 10.95±0.89 vs. 13.95±0.96nm, p=0.033, respectively. When comparing diabetic individuals with and without a diagnosis of PDN, one observed a greater flexion deficit among neuropathic individuals when compared with non-neuropathic individuals, 46.57±9.47 vs 11.63±13.85nm, p=0.049, respectively. No statistically significant differences were found when comparing groups exposed and unexposed to T2DM, and neuropathic and non-neuropathic diabetics.

Downloads

Download data is not yet available.

References

Pan American Health Organization. Health in the Americas 2012

edition: regional outlook and country profiles. Washington, DC:

Pan American Health Organization; 2012.

World Health Organization. Global status report on

noncommunicable diseases 2014. Geneva: World Health

Organization; 2014.

Ministério da Saúde (BR). Secretaria de Vigilância em Saúde.

Departamento de Análise e Situação de Saúde. Plano de ações

estratégicas para o enfrentamento das doenças crônicas

não transmissíveis (DCNT) no Brasil, 2011-2022. Brasília, DF:

Ministério da Saúde; 2011.

World Health Organization. Fact sheets: noncommunicable

diseases. Geneva: World Health Organization; 2015.

Oliveira JEP, Vencio S, editors. Diretrizes da Sociedade Brasileira

de Diabetes: 2014-2015. São Paulo: AC Farmacêutica; 2015.

World Health Organization. Definition, diagnosis and

classification of diabetes mellitus and its complications: report

of a WHO Consultation. Part 1: diagnosis and classification of

diabetes mellitus. Geneva: World Health Organization; 1999.

American Diabetes Association. Diagnosis and classification

of diabetes mellitus Diabetes Care. 2013;36(1):S67-74. doi:

2337/dc13-S067

Vukojević Z, Pekmezović T, Nikolić A, Perić S, Basta I, Marjanović,

et al. Correlation of clinical and neurophysiological findings

with health related quality of life in patients with diabetic

polyneuropathy. Vojnosanit Pregl. 2014;71(9):833-8. doi:

2298/VSP120919015V

Mochizuki Y, Tanaka H, Matsumoto K, Sano H, Toki H, Shimoura

H, et al. Association of peripheral nerve conduction in diabetic

neuropathy with subclinical left ventricular systolic dysfunction.

Cardiovasc Diabetol. 2015;14:47. doi: 10.1186/s12933-015-0213-4

Park SW, Goodpaster BH, Strotmeyer ES, Kuller LH, Broudeau R,

Kammerer C, et al. Accelerated loss of skeletal muscle strength

in older adults with type 2 diabetes: the health, aging, and

body composition study. Diabetes Care. 2007;30(6):1507-12.

doi: 10.2337/dc06-2537

Sacchetti MS, Balducci S, Bazzucchi I, Carlucci F, Palumbo A,

Haxhi J, et al. Neuromuscular dysfunction in diabetes: role of

motor nerve impairment and training status. Med Sci Sports

Exerc. 2013;45(1):52-9. doi: 10.1249/MSS.0b013e318269f9bb

Orlando G, Balducci S, Bazzucchi I, Pugliese G, Sacchetti M.

Neuromuscular dysfunction in type 2 diabetes: underlying

mechanisms and effect of resistance training. Diabetes Metab

Res Rev. 2016;32(1):40-50. doi: 10.1002/dmrr.2658

Balducci S, Sacchetti M, Orlando G, Salvi L, Pugliese L, Salerno

G, et al. Correlates of muscle strength in diabetes: the study on

the assessment of determinants of muscle and bone strength

abnormalities in diabetes (SAMBA). Nutr Metab Cardiovasc

Dis. 2014;4(1):18-26. doi: 10.1016/j.numecd.2013.04.010

Parmenter BJ, Raymond J, Dinnen PJ, Lusby RJ, Singh

MAF. Preliminary evidence that low ankle-brachial index is

associated with reduced bilateral hip extensor strength and

functional mobility in peripheral arterial disease. J Vasc Surg.

;57(4):963-73. doi: 10.1016/j.jvs.2012.08.103

Andreassen CS, Jakobsen J, Ringgaard S, Ejskjaer N, Andersen

H. Accelerated atrophy of lower leg and foot muscles: a followup study of long-term diabetic polyneuropathy using magnetic

resonance imaging (MRI). Diabetologia. 2009;52(6):1182-91.

doi: 10.1007/s00125-009-1320-0

Allen MD, Kimpinski K, Doherty TJ, Rice CL. Decreased muscle

endurance associated with diabetic neuropathy may be

attributed partially to neuromuscular transmission failure. J Appl

Physiol. 2015;118(8):1014-22. doi: 10.1152/japplphysiol.00441.2014

Ijzerman TH, Schaper NC, Melai T, Meijer K, Willems PJB,

Savelberg HHCM. Lower extremity muscle strength is reduced in

people with type 2 diabetes, with and without polyneuropathy,

and is associated with impaired mobility and reduced quality

of life. Diabetes Res Clin Pract. 2012;95(3):345-51. doi: 10.1016/j.

diabres.2011.10.026

Bianchi L, Zuliani G, Volpato S. Physical disability in the elderly

with diabetes: epidemiology and mechanisms. Curr Diab Rep.

;13(6):824-30. doi: 10.1007/s11892-013-0424-6

Gregg EW, Beckles GL, Williamson DF, Leveille SG, Langlois

JA, Engelgau MM, et al. Diabetes and physical disability among

older U.S. adults. Diabetes Care. 2000;23(9):1272-7. doi: 10.2337/

diacare.23.9.1272

Sayer AA, Dennison EM, Syddall HE, Gilbody HJ, Phillips DIW,

Cooper C. Type 2 diabetes, muscle strength, and impaired

physical function: the tip of the iceberg? Diabetes Care.

;28(10):2541-2. doi: 10.2337/diacare.28.10.2541

Andersen H, Nielsen S, Mogensen CE, Jakobsen J. Muscle

strength in type 2 diabetes. Diabetes. 2004;53(6):1543-8. doi:

2337/diabetes.53.6.1543

Bokan V. Muscle weakness and other late complications of

diabetic polyneuropathy. Acta Clin Croat [Internet]. 2011 [cited

Apr 24];50(3):351-5. Available from: hrcak.srce.hr/84096

Halvatsiotis P, Short KR, Bigelow M, Nair KS. Synthesis rate of

muscle proteins, muscle functions, and amino acid kinetics in

type 2 diabetes. Diabetes. 2002;51(8):2395-404. doi: 10.2337/

diabetes.51.8.2395

Andreassen CS, Jakobsen J, Andersen H. Muscle weakness:

a progressive late complication in diabetic distal symmetric

polyneuropathy. Diabetes. 2006;55(3):806-12. doi: 10.2337/

diabetes.55.03.06.db05-1237

Hawley J, Zierath JR, editors. Physical activity and type 2

diabetes: therapeutic effects and mechanisms of action.

Champaign: Human Kinetics; 2008.

Park SW, Goodpaster BH, Strotmeyer ES, Rekeneire N, Harris

TB, Schwartz AV, et al. Decreased muscle strength and quality

in older adults with type 2 diabetes: the health, aging, and body

composition study. Diabetes. 2006;55(6):1813-8. doi: 10.2337/

db05-1183

Harbo T, Brincks J, Andersen H. Maximal isokinetic and isometric

muscle strength of major muscle groups related to age, body

mass, height, and sex in 178 healthy subjects. Eur J Appl Physiol.

;112(1):267-75. doi: 10.1007/s00421-011-1975-3

Jones EJ, Bishop PA, Woods AK, Green JM. Cross-sectional

area and muscular strength: a brief review. Sports Med.

;38(12):987-94. doi: 10.2165/00007256-200838120-00003

Boshra H, Bahrpeyma F, Tehrani MRM. The comparison of

muscle strength and short term endurance in the different

periods of type 2 diabetes. J Diabetes Metab Disord. 2014;13:22.

doi: 10.1186/2251-6581-13-22

Ijzerman TH, Schaper NC, Melai T, Blijham P, Meijer K, Willems

PJB, et al. Motor nerve decline does not underlie muscle

weakness in type 2 diabetic neuropathy. Muscle Nerve.

;44(2):241-5. doi: 10.1002/mus.22039

Allen MD, Major B, Kimpinski K, Doherty TJ, Rice CL. Skeletal

muscle morphology and contractile function in relation to

muscle denervation in diabetic neuropathy. J Appl Physiol.

;116(5):545-52. doi: 10.1152/japplphysiol.01139.2013

Comparison between muscle strength and flexibility of the lower limbs of individuals with and without type 2 diabetes mellitus

Authors

DOI:

Keywords:

Abstract

Downloads

References

Downloads

Published

Issue

Section

License

How to Cite

Keywords

Language

Information